Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China flag China · Delayed Price · Currency is CNY
58.63
-0.97 (-1.63%)
Apr 16, 2026, 4:00 PM EDT

Suzhou Highfine Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
110.84134.0598.97129.37111.4
Depreciation & Amortization
37.8919.9914.1911.666.86
Other Amortization
0.370.080.180.120.06
Loss (Gain) From Sale of Assets
0.910.0300.120.03
Asset Writedown & Restructuring Costs
13.470.360.080.281.79
Loss (Gain) From Sale of Investments
-17.25-16.59-1.73-0.4-1.18
Other Operating Activities
5.671.614.97-3.442.42
Change in Accounts Receivable
146.15-25.75-18.725.08-45.34
Change in Inventory
-13.75-4.37-6.08-35.35-26.57
Change in Accounts Payable
-211.3713.14-6.5432.0927.37
Change in Other Net Operating Assets
7.934.542.230.590.33
Operating Cash Flow
77.67126.3787.83138.6775.97
Operating Cash Flow Growth
-38.54%43.88%-36.66%82.53%-14.80%
Capital Expenditures
-210.63-107.75-120.47-81.4-53.56
Sale of Property, Plant & Equipment
0.160.080.860.050
Cash Acquisitions
-55.6----
Investment in Securities
320.68-1,31029.47-15-35
Other Investing Activities
42.15478.15-475.212.1346.7
Investing Cash Flow
96.76-939.35-565.36-94.23-41.85
Long-Term Debt Issued
114.47----
Total Debt Issued
114.47----
Short-Term Debt Repaid
-----1
Long-Term Debt Repaid
-195.99-2.31-1.41-1.5-0.85
Total Debt Repaid
-195.99-2.31-1.41-1.5-1.85
Net Debt Issued (Repaid)
-81.52-2.31-1.41-1.5-1.85
Issuance of Common Stock
4.6-1,683--
Repurchase of Common Stock
--42---
Common Dividends Paid
-43.44-40.19-27-20.25-0.01
Other Financing Activities
-1.95--21.17--
Financing Cash Flow
-122.31-84.51,634-21.75-1.86
Foreign Exchange Rate Adjustments
-6.713.33-0.011.98-2.33
Net Cash Flow
45.4-894.161,15624.6729.93
Free Cash Flow
-132.9618.62-32.6457.2722.42
Free Cash Flow Growth
---155.48%3.12%
Free Cash Flow Margin
-22.08%4.12%-8.40%12.80%6.07%
Free Cash Flow Per Share
-1.240.17-0.350.710.28
Cash Income Tax Paid
34.9811.7322.3716.5820.47
Levered Free Cash Flow
-83.86-59.8-100.3117.22-1.56
Unlevered Free Cash Flow
-83.86-59.74-100.2817.37-1.5
Change in Working Capital
-74.23-13.16-28.830.95-45.42
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.